Your browser doesn't support javascript.
loading
Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma.
Budde, Axel; Baust, Katja; Weinhold, Leonie; Bernstein, Mark; Bielack, Stefan; Dhooge, Catharina; Hjorth, Lars; Janeway, Katherine A; Jenney, Meriel; Krailo, Mark D; Marina, Neyssa; Nagarajan, Rajaram; Smeland, Sigbjørn; Sydes, Matthew R; De Vos, Patricia; Whelan, Jeremy; Wiener, Andreas; Calaminus, Gabriele; Schmid, Matthias.
Afiliação
  • Budde A; Department of Paediatric Haematology and Oncology, University Hospital Bonn, Bonn, Germany. Electronic address: axel.budde@ukbonn.de.
  • Baust K; Department of Paediatric Haematology and Oncology, University Hospital Bonn, Bonn, Germany.
  • Weinhold L; Department of Medical Biometry, Informatics, and Epidemiology, University Hospital Bonn, Bonn, Germany.
  • Bernstein M; IWK Health Centre, Dalhousie University, Halifax, NS, Canada.
  • Bielack S; Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie, Klinikum Stuttgart, Olgahospital, Stuttgart, Germany.
  • Dhooge C; Department of Internal Medicine and Paediatrics, Faculty of Medicine and Health Sciences, Ghent University Hospital, Ghent, Belgium.
  • Hjorth L; Department of Clinical Sciences, Department of Paediatrics, Lund University, Skane University Hospital, Lund, Sweden.
  • Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
  • Jenney M; Women's Services Clinical Board, University Hospital of Wales, Cardiff, UK.
  • Krailo MD; Statistics and Data Center, Children's Oncology Group, Monrovia, CA, USA.
  • Marina N; Five Prime Therapeutics, South San Francisco, CA, USA.
  • Nagarajan R; Division of Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Smeland S; Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • De Vos P; Department of Paediatric Haematology and Oncology, Ghent University Hospital, Ghent, Belgium.
  • Whelan J; Department of Oncology, University College Hospital, London, UK.
  • Wiener A; West German Proton Therapy Center Essen, Essen, Germany.
  • Calaminus G; Department of Paediatric Haematology and Oncology, University Hospital Bonn, Bonn, Germany.
  • Schmid M; Department of Medical Biometry, Informatics, and Epidemiology, University Hospital Bonn, Bonn, Germany.
Eur J Cancer ; 170: 209-235, 2022 07.
Article em En | MEDLINE | ID: mdl-35689897
ABSTRACT

PURPOSE:

The available questionnaires for quality-of-life (QoL) assessments are age-group specific, limiting comparability and impeding longitudinal analyses. The comparability of measurements, however, is a necessary condition for gaining scientific evidence. To overcome this problem, we assessed the viability of harmonising data from paediatric and adult patient-reported outcome (PRO) measures.

METHOD:

To this end, we linked physical functioning scores from the Paediatric Quality of Life Inventory (PedsQL) and the Paediatric Quality of Life Questionnaire (PEDQOL) to the European Organisation for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30) for adults. Samples from the EURAMOS-1 QoL sub-study of 75 (PedsQL) and 112 (PEDQOL) adolescent osteosarcoma patients were concurrently administered both paediatric and adult questionnaires on 98 (PedsQL) and 156 (PEDQOL) occasions. We identified corresponding scores using the single-group equipercentile linking method.

RESULTS:

Linked physical functioning scores showed sufficient concordance to the EORTC QLQ-C30 Lin's ρ = 0.74 (PedsQL) and Lin's ρ = 0.64 (PEDQOL).

CONCLUSION:

Score linking provides clinicians and researchers with a common metric for assessing QoL with PRO measures across the entire lifespan of patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Osteossarcoma Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Limite: Adolescent / Adult / Child / Female / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Neoplasias da Mama / Osteossarcoma Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Limite: Adolescent / Adult / Child / Female / Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article